We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Molecular Trojan Horse Delivers Chemo Drug to Cancer Cells

News   Feb 26, 2018 | Original story from University of California, Riverside

 
Molecular Trojan Horse Delivers Chemo Drug to Cancer Cells

Schematic illustration of the developed cancer targeting agent -- 123B9 in this study. The compound (right panel) has a scorpion-like shape with two arms grabbing EphA2-expressing cancer cells, and a tail (brown) constituted by a cytotoxic chemotherapeutic agent (paclitaxel used in this work). The agent would recognize the surface of cancer cells rich in EphA2 (labeled in red in the left panel which shows cancer cells) and deliver the cytotoxic agent. Credit: Pellecchia lab, UC Riverside.

 
 
 

RELATED ARTICLES

Investigators Identify Potential Lung Cancer Markers

News

Investigators have identified markers that can distinguish between major subtypes of lung cancer and can accurately identify lung cancer stage, by examining both blood samples and tumor tissues from patients with non-small-cell lung cancer.

READ MORE

Human Pancreas-on-a-Chip Helps Identify Cause of Cystic Fibrosis Complication

News

Scientists have created human pancreas-on-a-chip that will enable them to identify the possible cause of a frequent and deadly complication of cystic fibrosis called CF-related diabetes, or CFRD.

READ MORE

Protein Gives Identical Cells Individuality

News

New insight into a protein's role in regulating tight DNA packing could have implications for combating tumor cell resistance to anti-cancer treatments.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE